LIFE has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
This is the historical short interest of aTyr Pharma Inc, as measured by the Short Percentage Of Shares Outstanding.
This the Institutional Ownership History of aTyr Pharma IncPeter Lynch prefers to buy companies with low institutional ownership.
This is the historical insider ownership of aTyr Pharma Inc. It is usually better to buy companies with large insider ownership. The company insiders' interest are more aligned with external shareholders in this case.
|April 30, 2015||2|
|Holder||Position||Shares||% of Shares |
|Dr. John D. Mendlein||N/A||245,971||1.09%||2015-05-12|
|John K. Clarke||N/A||104,878||0.47%||2015-05-12|
|Ms. Melissa A. Ashlock||N/A||68,164||0.3%||2015-05-06|
|Mr. Frederic Chereau||N/A||12,867||less than 0.1%||2015-05-06|
|Kathryn E. Falberg||N/A||12,572||less than 0.1%||2015-05-06|
|Amir Nashat||N/A||12,572||less than 0.1%||2015-05-12|
|Dr. Paul R. Schimmel,PhD||N/A||12,572||less than 0.1%||2015-05-12|
|Dr. David M. Weiner, M.D.||N/A||5,028||less than 0.1%||2015-05-06|
|Mr. Stan Blackburn||N/A||2,149||less than 0.1%||2015-05-06|
|Mr. Holly D. Chrzanowski||N/A||1,885||less than 0.1%||2015-05-06|
|Holder||Shares||Report Date||% of Shares |
|% of Total |
|Sofinnova Venture Partners IX LP||1,866,126||2015-05-06||0.00||0.00||0|
|Deerfield Management Co||511,528||2015-05-12||0.00||0.00||0|